Algorhythm Holdings Q2 EPS $(0.25) beats $(0.36) estimate

3 min read     Updated on 14 Aug 2026, 07:59 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Algorhythm Holdings Inc (NASDAQ: RIME) reported Q2 2026 EPS of $(0.25), beating the $(0.36) consensus by 30.56%. Revenue of $3.005 million also beat the $3.000 million estimate, up 161% YoY. Net loss widened to $3.8 million as operating expenses rose to $2.1 million. Gross margin improved sequentially but remains negative.

powered bylight_fuzz_icon
48263086

*this image is generated using AI for illustrative purposes only.

Algorhythm Holdings Inc (NASDAQ: RIME) reported second quarter 2026 earnings per share of $(0.25), beating the analyst consensus estimate of $(0.36) by 30.56%. The company’s quarterly sales of $3.005 million also surpassed the consensus estimate of $3.000 million by 0.17%. This represents a 161% year-over-year increase in revenue from $1.2 million in the same period last year, and a 25% sequential growth from $2.4 million in Q1 2026.

Despite the top-line growth and better-than-expected per-share loss, the company recorded a net loss attributable to common shareholders of $3.8 million for the quarter, compared to a loss of $585,000 in Q2 2025. The results reflect continued investment in business development and expansion efforts, particularly in North America and India.

Financial Performance

The company’s gross margin percentage improved by approximately 30% sequentially, or 850 basis points, according to management commentary. However, the income statement reveals a gross loss of $593,000 for the quarter, as cost of sales ($3.6 million) exceeded net sales ($3.0 million). This contrasts with a gross loss of $340,000 in Q2 2025.

Operating expenses rose significantly to $2.1 million in Q2 2026, up from $868,000 in the prior year period. General and administrative expenses accounted for the bulk of this increase at $2.1 million, while selling expenses were logged at $49,000. The company also reported other expenses totaling $1.4 million, including $1.0 million in net interest expense and a $400,000 loss on debt extinguishment.

Metric Q2 2026 Q2 2025 Change
Net Sales $3.005 million $1.2 million +161%
Cost of Sales $3.6 million $1.5 million N/A
Gross Loss $(593,000) $(340,000) Widened
Operating Expenses $2.1 million $868,000 Increased
Net Loss (Common) $(3.8 million) $(585,000) Widened
EPS $(0.25) $(0.24) Worse

Balance Sheet and Cash Position

As of June 30, 2026, Algorhythm Holdings held total cash and restricted cash of approximately $8.0 million. Unrestricted cash stood at $5.0 million, while restricted cash was $3.0 million. Total assets grew 46% to $18.6 million from $12.7 million at the end of FY25.

Total liabilities increased to $15.3 million from $14.6 million in the previous fiscal year-end. Current liabilities were $14.9 million, driven by promissory notes payable of $6.4 million and accrued expenses of $3.1 million. Shareholders’ equity turned positive, standing at $3.3 million compared to a deficit of $1.9 million at December 31, 2025.

What the Numbers Show

A key divergence exists between the reported sequential margin improvement and the absolute gross loss. While management highlighted an 850-basis-point sequential improvement in gross margin percentage, the company still incurred a gross loss of $593,000 against $3.0 million in revenue. This indicates that while cost efficiency relative to revenue has improved from Q1, the core operations remain unprofitable on a gross basis, with cost of sales exceeding net sales by nearly 20%.

The beat on EPS estimates was driven by lower-than-expected losses per share, despite the widened absolute net loss compared to the prior year. The slight miss on the revenue estimate ($3.005 million vs $3.000 million expected) suggests precise forecasting accuracy from analysts, though the actual figure slightly exceeded expectations.

Business Updates

During the quarter, Algorhythm expanded its SemiCab platform presence through several strategic moves:

  • Expanded its relationship with Procter & Gamble India, increasing the annualized contract value by approximately 32%.
  • Signed a new Master Services Agreement with Onida Electronics, broadening its enterprise customer portfolio in India.
  • Hired Jonathan Miller as Vice President of U.S. Sales to drive commercial expansion of the SemiCab Apex SaaS platform in North America.
  • Participated as a Gold Sponsor at Reuters Events: Supply Chain USA 2026 and hosted its inaugural SemiCab Freight Network Forum.

Gary Atkinson, Chief Executive Officer, stated that the company will focus on financial discipline and controlling costs while evaluating acquisition opportunities to enhance long-term shareholder value.

Given the widening gross loss despite improved margin percentages, what specific operational changes are required for Algorhythm to achieve positive gross profitability in the near term?

How will the hiring of a U.S. Sales VP and expansion efforts in North America impact the company's burn rate and path to cash flow positivity?

With $6.4 million in promissory notes payable, what is the company's strategy for managing debt maturity and interest expenses while pursuing potential acquisitions?

like16
dislike

Algorhythm ARR rises 20% to $12 million in March 2026

1 min read     Updated on 07 Jul 2026, 11:37 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Algorhythm Holdings reported a $12 million ARR in March 2026, up 20% from December 2025, with Q1 revenue growing over 71% sequentially and 1,800% year-over-year. New contracts with Coca Cola India and Onida Electronics drove growth in India, while the U.S. expansion saw the appointment of a new VP of Sales. A $9.5 million capital infusion in February further strengthened the company's financial position.

powered bylight_fuzz_icon
44993257

*this image is generated using AI for illustrative purposes only.

Algorhythm Holdings, Inc. achieved a $12 million annualized revenue run rate (ARR) in March 2026, reflecting a more than 20% increase from the $10 million ARR attained in December 2025. The company reported first quarter revenue growth of more than 71% sequentially and more than 1,800% year-over-year. To support this expansion, Algorhythm completed a $9.5 million capital infusion in February, significantly strengthening its cash position during the first half of 2026.

The company’s flagship platform, SemiCab, secured market adoption from new brands including Coca Cola India and Onida Electronics. It also expanded contracts with existing customers such as Apollo Tyres, Unilever India, and Proctor & Gamble India. These entities utilize SemiCab’s AI-enabled global freight optimization platform to manage shipments across key domestic transportation lanes in India.

Algorhythm advanced its U.S. market penetration efforts for the SemiCab Apex SaaS offering. In March, the company appointed Jonthan Miller as VP of Sales to lead business development. Mr. Miller brings nearly 30 years of logistics and freight technology leadership experience, having held senior roles at DAT Freight & Analytics, FourKites, GT Nexus, E2open, One Network, and i2 Technologies.

To bolster its public profile, SemiCab launched the Freight Network Forum, an online series for senior supply chain leaders. The company also attended Reuters Events: Supply Chain USA 2026 in Chicago as a Gold Sponsor. Algorhythm CEO Gary Atkinson and SemiCab CEO Ajesh Kapoor discussed AI technology adoption in logistics through media appearances on Fox Business, Bloomberg TV, and Nasdaq TV (TradeTalks).

Financial Highlights

Metric Value
Annualized Revenue Run Rate (March 2026) $12 million
Annualized Revenue Run Rate (December 2025) $10 million
Q1 Sequential Revenue Growth >71%
Q1 Year-Over-Year Revenue Growth >1,800%
Capital Infusion (February 2026) $9.5 million

Algorhythm Holdings CEO Gary Atkinson stated that the teams have worked diligently to position the company for long-term success. He noted that SemiCab is generating new contracts and expansions in India, while the Apex SaaS offering is attracting interest in the U.S. and Europe from major global companies. The company remains focused on converting its growing pipeline into commercial relationships and evaluating opportunities to enhance long-term shareholder value.

How will the recent $9.5 million capital infusion specifically be allocated to accelerate U.S. and European market penetration?

What is the expected timeline for converting the current sales pipeline into commercial contracts for the SemiCab Apex SaaS offering?

Can the rapid Q1 revenue growth rate be sustained throughout the remainder of 2026 as the company scales operations?

like18
dislike

More News on Algorhythm Holdings Inc